scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

16 Sep 2017-The Lancet (Elsevier)-Vol. 390, Iss: 10100, pp 1211-1259
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
About: This article is published in The Lancet.The article was published on 2017-09-16 and is currently open access. It has received 10401 citations till now. The article focuses on the topics: Mortality rate.
Citations
More filters
Journal ArticleDOI
TL;DR: Depressive disorders are prevalent but poorly recognized in Chinese older adults receiving treatment in primary care clinics, and it is time to integrate the management of common mental disorders into primary healthcare in China.

44 citations

Journal ArticleDOI
TL;DR: Overall, participants enrolled in Tai Chi had better balance, gait and flexibility, less fatigue and depression, and better quality of life after the intervention; though mixed results were reported.

44 citations

Journal ArticleDOI
TL;DR: It is indicated that later-born Europeans have substantially better cognitive functioning than earlier-born cohorts, and for physical functioning, improvements were less clear, but for Northern Europe there was an improvement in ADL and IADL in the oldest age groups.
Abstract: Background Adult mortality has been postponed over time to increasingly high ages. However, evidence on past and current health trends has been mixed, and little is known about European disability trends. Methods In a cross-sectional setting, we compared cognitive and physical functioning in same-aged Europeans aged 50+ between 2004-05 (wave 1; n = 18 757) and 2013 (wave 5 refresher respondents; n = 16 696), sourced from the Survey of Health, Ageing and Retirement in Europe (SHARE). Results People in 2013 had better cognitive function compared with same-aged persons in 2004-05, with an average difference of approximately one-third standard deviation. The same level of cognitive function in 2004-05 at age 50 was found in 2013 for people who were 8 years older. There was an improvement in cognitive function in all European regions. Mean grip strength showed an improvement in Northern Europe of 1.00 kg [95% confidence interval (CI) 0.65; 1.35] and in Southern Europe of 1.68 kg (95% CI 1.14; 2.22), whereas a decrease was found in Central Europe (-0.80 kg; 95% CI -1.16; -0.44). We found no overall differences in activities of daily living (ADL), but small improvements in instrumental activities of daily living (IADL) in Northern and Southern Europe, with an improvement in both ADL and IADL from age 70 in Northern Europe. Conclusions Our results indicate that later-born Europeans have substantially better cognitive functioning than earlier-born cohorts. For physical functioning, improvements were less clear, but for Northern Europe there was an improvement in ADL and IADL in the oldest age groups.

44 citations

Journal ArticleDOI
Christopher S. Crowe1, Benjamin B. Massenburg1, Shane D. Morrison1, James Chang2, Jeffrey B. Friedrich1, Gdiom Gebreheat Abady3, Fares Alahdab4, Vahid Alipour5, Jalal Arabloo5, Malke Asaad6, Maciej Banach7, Maciej Banach8, Ali Bijani9, Antonio Maria Borzì10, Nikolay Ivanovich Briko11, Chris D Castle12, Daniel Y. Cho1, Michael T. Chung13, Ahmad Daryani14, Gebre Teklemariam Demoz15, Gebre Teklemariam Demoz16, Zachary V Dingels12, Hoa Thi Do, Florian Fischer17, Jack T Fox12, Takeshi Fukumoto, Abadi Kahsu Gebre18, Berhe Gebremichael19, Juanita A. Haagsma20, Arvin Haj-Mirzaian, Demelash Woldeyohannes Handiso, Simon I. Hay, Chi Linh Hoang, Seyed Sina Naghibi Irvani21, Jacek Jerzy Jozwiak22, Rohollah Kalhor23, Amir Kasaeian, Yousef Khader24, Rovshan Khalilov25, Ejaz Ahmad Khan26, Roba Khundkar27, Sezer Kisa28, Adnan Kisa29, Zichen Liu12, Marek Majdan, Navid Manafi5, Navid Manafi30, Ali Manafi5, Ana Laura Manda, Tuomo J. Meretoja31, Ted R. Miller32, Ted R. Miller33, Abdollah Mohammadian-Hafshejani34, Reza Mohammadpourhodki35, Mohammad A. Mohseni Bandpei, Ali H. Mokdad, Mukhammad David Naimzada, Duduzile Ndwandwe36, Cuong Tat Nguyen37, Huong Lan Thi Nguyen37, Andrew T Olagunju, Tinuke O Olagunju38, Hai Quang Pham37, Dimas Ria Angga Pribadi39, Navid Rabiee40, Kiana Ramezanzadeh21, Kavitha Ranganathan41, Nicholas L S Roberts12, Leonardo Roever42, Saeed Safari21, Abdallah M. Samy43, Lidia Sanchez Riera, Saeed Shahabi44, Catalin Gabriel Smarandache, Dillon O Sylte12, Berhe Etsay Tesfay3, Bach Xuan Tran45, Irfan Ullah, Parviz Vahedi46, Amir Vahedian-Azimi47, Theo Vos, Dawit Habte Woldeyes48, Adam Belay Wondmieneh, Zhi-Jiang Zhang49, Spencer L. James12 
University of Washington1, Stanford University2, Adigrat University3, Mayo Clinic4, Iran University of Medical Sciences5, University of Texas Health Science Center at Houston6, Medical University of Łódź7, Memorial Hospital of South Bend8, Babol University of Medical Sciences9, University of Catania10, I.M. Sechenov First Moscow State Medical University11, Institute for Health Metrics and Evaluation12, Wayne State University13, Mazandaran University of Medical Sciences14, Addis Ababa University15, Aksum University16, Bielefeld University17, Mekelle University18, Haramaya University19, Erasmus University Medical Center20, Shahid Beheshti University of Medical Sciences and Health Services21, Opole University22, Qazvin University of Medical Sciences23, Jordan University of Science and Technology24, Baku State University25, Health Services Academy26, University of Oxford27, University of Oslo28, RMIT University29, University of Manitoba30, University of Helsinki31, Pacific Institute32, Curtin University33, Shahrekord University of Medical Sciences34, Shahroud University of Medical Sciences35, South African Medical Research Council36, Duy Tan University37, McMaster University38, Muhammadiyah University of Surakarta39, Sharif University of Technology40, University of Michigan41, Federal University of Uberlandia42, Ain Shams University43, Shiraz University of Medical Sciences44, Hanoi Medical University45, University of Maragheh46, Baqiyatallah University of Medical Sciences47, Bahir Dar University48, Wuhan University49
TL;DR: Low-middle and middle SDI countries, however, have demonstrated increasing rates of fracture and amputation over the last 27 years, concerning as access to quality and subspecialised surgical hand care is often limiting in these resource-limited regions.
Abstract: Background As global rates of mortality decrease, rates of non-fatal injury have increased, particularly in low Socio-demographic Index (SDI) nations. We hypothesised this global pattern of non-fatal injury would be demonstrated in regard to bony hand and wrist trauma over the 27-year study period. Methods The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 was used to estimate prevalence, age-standardised incidence and years lived with disability for hand trauma in 195 countries from 1990 to 2017. Individual injuries included hand and wrist fractures, thumb amputations and non-thumb digit amputations. Results The global incidence of hand trauma has only modestly decreased since 1990. In 2017, the age-standardised incidence of hand and wrist fractures was 179 per 100 000 (95% uncertainty interval (UI) 146 to 217), whereas the less common injuries of thumb and non-thumb digit amputation were 24 (95% UI 17 to 34) and 56 (95% UI 43 to 74) per 100 000, respectively. Rates of injury vary greatly by region, and improvements have not been equally distributed. The highest burden of hand trauma is currently reported in high SDI countries. However, low-middle and middle SDI countries have increasing rates of hand trauma by as much at 25%. Conclusions Certain regions are noted to have high rates of hand trauma over the study period. Low-middle and middle SDI countries, however, have demonstrated increasing rates of fracture and amputation over the last 27 years. This trend is concerning as access to quality and subspecialised surgical hand care is often limiting in these resource-limited regions.

43 citations

Journal ArticleDOI
TL;DR: This systematic review aims to summarize the existing literature regarding sociodemographic factors, psychopathology, and course of disease in patients with CD in comparison to patients with non‐CD.
Abstract: Background There is still uncertainty if and to what extent chronic depression (CD) presents with specific features especially in contrast to the nonchronic course of major depressive disorder (non-CD). This systematic review aims to summarize the existing literature regarding sociodemographic factors, psychopathology, and course of disease in patients with CD in comparison to patients with non-CD. Methods A structured database search (MEDLINE, PsycINFO, Web of Science, CENTRAL) was performed. All studies comparing CD with non-CD patients were included. Twenty-eight studies, including cohort studies, cross-sectional studies, and observational studies, were identified in which both subgroups were diagnosed according to DSM-IV or DSM-5, respectively. Primary outcome were group comparisons focused on sociodemographic factors, childhood adversity, onset of the disorder, comorbidities, severity and course of the depressive symptoms, and specific psychopathology. Results Patients with CD had an earlier onset of depressive symptoms, higher rates of psychiatric comorbidities, and a complicated treatment course (e.g., higher rates of suicidality) compared to non-CD. We also found some evidence for specific features in the psychopathology of CD patients (submissive and hostile interpersonal styles) in contrast to non-CD patients. Results were inconsistent with regard to childhood maltreatment. No differences were found regarding the severity of depressive symptoms and most sociodemographic factors. Conclusion Despite some inconsistencies, the results of this review verified important differences between CD and non-CD. However, future research is needed to characterize especially the specific psychopathology of CD in comparison to non-CD patients to develop more tailored treatment strategies.

43 citations

References
More filters
Reference EntryDOI
11 Jun 2013

113,134 citations

Journal ArticleDOI
TL;DR: In this paper, a randomized clinical trial was conducted to evaluate the effect of preterax and Diamicron Modified Release Controlled Evaluation (MDE) on the risk of stroke.
Abstract: ABI : ankle–brachial index ACCORD : Action to Control Cardiovascular Risk in Diabetes ADVANCE : Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation AGREE : Appraisal of Guidelines Research and Evaluation AHA : American Heart Association apoA1 : apolipoprotein A1 apoB : apolipoprotein B CABG : coronary artery bypass graft surgery CARDS : Collaborative AtoRvastatin Diabetes Study CCNAP : Council on Cardiovascular Nursing and Allied Professions CHARISMA : Clopidogrel for High Athero-thrombotic Risk and Ischemic Stabilisation, Management, and Avoidance CHD : coronary heart disease CKD : chronic kidney disease COMMIT : Clopidogrel and Metoprolol in Myocardial Infarction Trial CRP : C-reactive protein CURE : Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD : cardiovascular disease DALYs : disability-adjusted life years DBP : diastolic blood pressure DCCT : Diabetes Control and Complications Trial ED : erectile dysfunction eGFR : estimated glomerular filtration rate EHN : European Heart Network EPIC : European Prospective Investigation into Cancer and Nutrition EUROASPIRE : European Action on Secondary and Primary Prevention through Intervention to Reduce Events GFR : glomerular filtration rate GOSPEL : Global Secondary Prevention Strategies to Limit Event Recurrence After MI GRADE : Grading of Recommendations Assessment, Development and Evaluation HbA1c : glycated haemoglobin HDL : high-density lipoprotein HF-ACTION : Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing HOT : Hypertension Optimal Treatment Study HPS : Heart Protection Study HR : hazard ratio hsCRP : high-sensitivity C-reactive protein HYVET : Hypertension in the Very Elderly Trial ICD : International Classification of Diseases IMT : intima-media thickness INVEST : International Verapamil SR/Trandolapril JTF : Joint Task Force LDL : low-density lipoprotein Lp(a) : lipoprotein(a) LpPLA2 : lipoprotein-associated phospholipase 2 LVH : left ventricular hypertrophy MATCH : Management of Atherothrombosis with Clopidogrel in High-risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke MDRD : Modification of Diet in Renal Disease MET : metabolic equivalent MONICA : Multinational MONItoring of trends and determinants in CArdiovascular disease NICE : National Institute of Health and Clinical Excellence NRT : nicotine replacement therapy NSTEMI : non-ST elevation myocardial infarction ONTARGET : Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial OSA : obstructive sleep apnoea PAD : peripheral artery disease PCI : percutaneous coronary intervention PROactive : Prospective Pioglitazone Clinical Trial in Macrovascular Events PWV : pulse wave velocity QOF : Quality and Outcomes Framework RCT : randomized clinical trial RR : relative risk SBP : systolic blood pressure SCORE : Systematic Coronary Risk Evaluation Project SEARCH : Study of the Effectiveness of Additional Reductions in Cholesterol and SHEP : Systolic Hypertension in the Elderly Program STEMI : ST-elevation myocardial infarction SU.FOL.OM3 : SUpplementation with FOlate, vitamin B6 and B12 and/or OMega-3 fatty acids Syst-Eur : Systolic Hypertension in Europe TNT : Treating to New Targets UKPDS : United Kingdom Prospective Diabetes Study VADT : Veterans Affairs Diabetes Trial VALUE : Valsartan Antihypertensive Long-term Use VITATOPS : VITAmins TO Prevent Stroke VLDL : very low-density lipoprotein WHO : World Health Organization ### 1.1 Introduction Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously throughout life and usually progressing to an advanced stage by the time symptoms occur. It remains the major cause of premature death in Europe, even though CVD mortality has …

7,482 citations

Journal ArticleDOI
TL;DR: Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S2 The goals of the …
Abstract: Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S2 The goals of the …

7,184 citations

Journal ArticleDOI
TL;DR: The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) as discussed by the authors provides a timely opportunity to update the comparative risk assessment with new data for exposure, relative risks, and evidence on the appropriate counterfactual risk distribution.

5,668 citations

Journal ArticleDOI
Gregory A. Roth1, Gregory A. Roth2, Degu Abate3, Kalkidan Hassen Abate4  +1025 moreInstitutions (333)
TL;DR: Non-communicable diseases comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5–74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional causes accounted for 18·6% (17·9–19·6), and injuries 8·0% (7·7–8·2).

5,211 citations